Skip to main content

Aggressive Breast Cancer Responds to New Drug

By
woman looking at mamagram image

In the clinical trial of the new drug, sacituzumab govitecan, about a third of the patients responded to treatment and the effect lasted up to eight months. The research was funded by the drug's maker.



from WebMD Health https://ift.tt/2EnqLcY
via IFTTT
Labels:

Comments

Post a Comment

Popular posts from this blog

The Future of Autoimmune Disorders: Psoriatic Disease

By
What's being done to help people with psoriatic disease? We get a look at the ever-changing picture from a rheumatologist. from WebMD Health https://ift.tt/5P6ZHyd via IFTTT
Post a Comment
Read more

FDA Panel Votes Unanimously for COVID Shots for Youngest Kids

By
FDA advisors lent strong support to expand authorization of the Pfizer and Moderna shots in young children. from WebMD Health https://ift.tt/5pBUDf1 via IFTTT
Post a Comment
Read more

Why Maintaining a Healthy Weight Is Important in Adulthood

By
Those who gained weight as adults had a higher risk of premature death than those who maintained a normal weight. Weight loss in young to middle adulthood was not significantly related with death risk. from WebMD Health https://ift.tt/33BL9RF via IFTTT
Post a Comment
Read more